Abstract
To directly compare clinical side effects and biological response modification, IFN-beta ser, IFN-gamma, or the combination of IFN-beta ser plus IFN-gamma was administered to 21 cancer patients. Each IFN or the combination was given intravenously on days 1, 8, and 15 in varied order. Each IFN and the combination resulted in significant (P less than 0.05) modulation of IFN-induced proteins. IFN-beta ser was more effective than IFN-gamma in enhancing 2-5A synthetase activity (P = 0.001). IFN-gamma was more effective than IFN-beta ser in enhancing serum beta 2 microglobulin expression (P = 0.05) and indoleamine dioxygenase activity, as assessed by decreased serum tryptophan (P = 0.03). The combination enhanced tryptophan catabolism more effectively than IFN-beta ser in a dose-dependent manner (P less than 0.03). IFN-beta ser/IFN-gamma did not potentiate natural killer cells or antibody-dependent cellular toxicity (ADCC). IFN-beta ser/IFN-gamma enhanced monocyte guanylate cyclase activity, as assessed by serum neopterin, more effectively than IFN-gamma alone (P = 0.005). Both IFNs and the combination resulted in increases in HLA class II expression on monocytes. However, no significant difference in the level of induction of HLA DQ...Continue Reading
References
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H YasuiO Hayaishi
Dec 1, 1986·Journal of Interferon Research·J H SchillerE C Borden
Aug 1, 1989·Journal of Interferon Research·D M PaulnockE C Borden
Aug 1, 1986·Journal of Interferon Research·G I ByrneR R Brown
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Y OzakiD S Duch
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C F NathanS E Krown
Jan 1, 1985·Journal of Interferon Research·J A MerrittL A Ball
Dec 1, 1970·Biochemical Medicine·R A ArendR R Brown
Jul 1, 1983·The Journal of Clinical Investigation·P M GuyreR Miller
Jul 1, 1984·The Journal of Experimental Medicine·C HuberH Wachter
Jun 4, 1984·Nature·C L SidmanH M Johnson
Citations
Nov 1, 1992·Physiology & Behavior·A S van MiertC T van Duin
Feb 22, 1992·Lancet·D MildvanS E Grossberg
Feb 1, 1996·Journal of Neuroimmunology·A MillerN Lahat
Oct 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·G FierlbeckJ Brzoska
Nov 23, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Snehal G ThakkarErnest C Borden
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·S D DerR H Silverman
Apr 1, 1996·Leukemia & Lymphoma·K RemesT T Pelliniemi
Dec 2, 2004·Expert Opinion on Emerging Drugs·Clyde Markowitz
Feb 24, 2009·Current Medical Research and Opinion·S Mitchell Freedman
May 3, 2014·Seminars in Oncology·Hyeonjoo CheonGeorge R Stark
Mar 16, 2011·Stem Cell Research & Therapy·Christopher D KrauseSidney Pestka
Jan 15, 1992·Cancer·J H SchillerD R Spriggs
Feb 1, 2019·Immunopharmacology and Immunotoxicology·Jarred NapierKyle B Walsh
Jan 1, 1992·Critical Reviews in Clinical Laboratory Sciences·D FuchsH Wachter
Sep 1, 1992·Arthritis and Rheumatism·R M SilverM P Heyes
Jan 15, 2011·Clinical Microbiology Reviews·Oludare A OdumadeHenry H Balfour
Jul 15, 2020·Microbiology and Immunology·Jun-Ichi MaeyamaShingou Sakurai
Jan 1, 2008·Biomarker Insights·Andreas NechanskyRalf Kircheis